Document Detail

The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium.
MedLine Citation:
PMID:  23211448     Owner:  NLM     Status:  Publisher    
Effective delivery of exogenous angiogenic growth factors can provide a new therapy for ischemic diseases. However, clinical translation of growth factor therapies faces multiples challenges; the most significant one is the short half-life of the naked protein. We use heparin and a nontoxic polycation to form an injectable coacervate that protects growth factors and preserves their bioactivities. Here we report the effectiveness of fibroblast growth factor-2 (FGF2) coacervate in reducing scar burden in a mouse myocardial infarction model. The coacervate provides spatial and temporal control of the release of heparin-binding proteins. Coacervate treated animals show lower level of inflammation, fibrosis and cardiomyocyte death in the infarcted myocardium. Histological evaluation indicates that FGF2 coacervate significantly increases the number of endothelial and mural cells and results in stable capillaries and arterioles to at least 6 weeks post injection. Echocardiographic assessment shows that FGF2 coacervate promotes cardiac contractibility and inhibits ventricular dilation, suggesting that the improvement at the tissue level leads to better cardiac functions. On the contrary, identical dosage of free FGF2 shows no statistical difference from saline or vehicle control in histological or functional assessment. Overall, injection of FGF2 coacervate ameliorated the ischemic injury caused by myocardial infarction. The promising data in rodent warrant further examination of the potential of clinical translation of this technology.
Hunghao Chu; Chien-Wen Chen; Johnny Huard; Yadong Wang
Related Documents :
24378998 - Cost-effectiveness of barostim therapy for the treatment of resistant hypertension in e...
24464788 - Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects...
23129008 - Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricul...
2257758 - Evidence for transcytosis of exogenous superoxide dismutase and catalase from coronary ...
9827478 - Perspectives of operative myocardial revascularization--minimally invasive coronary byp...
3573428 - Effect of mci-176, a new calcium antagonist, on the calcium induced contraction of isol...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-1
Journal Detail:
Title:  Biomaterials     Volume:  -     ISSN:  1878-5905     ISO Abbreviation:  Biomaterials     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100316     Medline TA:  Biomaterials     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Department of Bioengineering, University of Pittsburgh, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bone regeneration with BMP-2 delivered from keratose scaffolds.
Next Document:  Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles lo...